Presynaptic receptors for dopamine, histamine and serotonin that are located on dopaminergic, histaminergic and sertonergic axon terminals, respectively, function as autoreceptors. Presynaptic receptors also occur as heteroreceptors on other axon terminals. Auto- and heteroreceptors mainly affect Ca2+ -dependent exocytosis from the receptor-bearing nerve ending. Some additionally subserve other presynaptic functions.
Presynaptic dopamine, histamine and serotonin receptors are involved in various (patho)physiological conditions. Examples are the following:
Dopamine autoreceptors play a role in Parkinson’s disease, schizophrenia and drug addiction. Dopamine heteroreceptors affecting the release of acetylcholine and of amino acid neurotransmitters in the basal ganglia are also relevant for Parkinson’s disease. Peripheral dopamine heteroreceptors on postganglionic sympathetic terminals influence heart rate and vascular resistance through modulation of noradrenaline release.
Blockade of histamine autoreceptors increases histamine synthesis and release and may support higher CNS functions such as arousal, cognition and learning. Peripheral histamine heteroreceptors on C fiber and on postganglionic sympathetic fiber terminals diminish neuropeptide and noradrenaline release, respectively. Both inhibititory effects are beneficial in myocardial ischemia. The inhibition of neuropeptide release also explains the antimigraine effects of some agonists of presynaptic histamine receptors.
Upregulation of presynaptic serotonin autoreceptors is probably involved in the pathogenesis of major depression. Correspondingly, antidepressant treatments can be linked with a reduced density of 5-HT autoreceptors. 5-HT Heteroreceptor activation diminishes acetylcholine and GABA release and may therefore increase anxiety. In the periphery, presynaptic 5-HT heteroreceptor agonists shorten migraine attacks by inhibition of the release of neuropeptides from trigeminal afferents, apart from their constrictive action on meningeal vessels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian GK, Marek GJ (1999) Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res 825:161-71
Agneter E, Singer EA, Sauermann W, Feuerstein TJ (1997) The slope parameter of concentrationresponse curves used as a touchstone for the existence of spare receptors. NaunynSchmiedeberg’s Arch Pharmacol 356:283-92
Ago Y, Nakamura S, Baba A, Matsuda T (2005a) Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30:43-51
Ago Y, Harasawa T, Itoh S, Nakamura S, Baba A, Matsuda T (2005b) Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice. Eur J Pharmacol 520:86-90
Aizman O, Brismar H, Uhlen P, Zettergren E, Levey AI, Forssberg H, Greengard P, Aperia A (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3:226-30
Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55:242-51
Allgaier C, Warnke P, Stangl AP, Feuerstein TJ (1995) Effects of 5-HT receptor agonists on depolarization-induced [3 H]-noradrenaline release in rabbit hippocampus and human neocortex. Br J Pharmacol 116:1769-74
Anichtchik OV, Rinne JO, Kalimo H, Panula P (2000) An altered histaminergic innervation of the substantia nigra in Parkinson’s disease. Exp Neurol 163:20-30
Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P (2001) Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson’s disease. Neurobiol Dis 8:707-16
Aosaki T, Kiuchi K, Kawaguchi Y (1998) Dopamine D1 -like receptor activation excites rat striatal large aspiny neurons in vitro. J Neurosci 18:5180-90
Arias-Montano JA, Floran B, Garcia M, Aceves J, Young JM (2001) Histamine H3 receptormediated inhibition of depolarization-induced, dopamine D1 receptor-dependent release of [3 H]-gamma-aminobutryic acid from rat striatal slices. Br J Pharmacol 133:165-71
Arias-Montano JA, Floran B, Floran L, Aceves J, Young JM (2007) Dopamine D1 receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels. Synapse 61:310-19
Arbilla S, Nowak JZ, Langer SZ (1985) Rapid desensitization of presynaptic dopamine autoreceptors during exposure to exogenous dopamine. Brain Res 337:11-17
Arnsten AF, Cai JX, Steere JC, Goldman-Rakic PS (1995) Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J Neurosci 15:3429-39
Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3 ) of histamine receptor. Nature 302:832-7
Arrang JM, Garbarg M, Schwartz JC (1985) Autoregulation of histamine release in brain by presynaptic H3 -receptors. Neuroscience 15:553-62
Arrang JM, Drutel G, Schwartz JC (1995) Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex. Br J Pharmacol 114:1518-22
Arvanov VL, Liang X, Magro P, Roberts R, Wang RY (1999) A pre- and postsynaptic modulatory action of 5-HT and the 5-HT2A , 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Eur J Neurosci 11:2917-34
Asaumi Y, Hasuo H, Akasu T (2006) Dopamine presynaptically depresses fast inhibitory synaptic transmission via D4 receptor-protein kinase A pathway in the rat dorsolateral septal nucleus. J Neurophysiol 96:591-601
Azdad K, Piet R, Poulain DA, Oliet SH (2003) Dopamine D4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 90:559-65
Baimoukhametova DV, Hewitt SA, Sank CA, Bains JS (2004) Dopamine modulates use-dependent plasticity of inhibitory synapses. J Neurosci 24:5162-71
Bakker RA (2004) Histamine H3 -receptor isoforms. Inflamm Res 53:509-16
Bakker RA, Lozada AF, van Marle A, Shenton FC, Drutel G, Karlstedt K, Hoffmann M, Lintunen M, Yamamoto Y, van Rijn RM, Chazot PL, Panula P, Leurs R (2006) Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol Pharmacol 69:1194-1206
Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42:653-63
Batchelor M, Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304-9
Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg’s Arch Pharmacol 317:36-43
Bean AJ, During MJ, Roth RH (1990) Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex. Neurosci Lett 108:143-8
Bean AJ, Roth RH (1991) Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors. J Neurosci 11:2694-2702
Benkirane S, Arbilla S, Langer SZ (1987) A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3 H]-serotonin from the rat substantia nigra. Naunyn-Schmiedeberg’s Arch Pharmacol 335:502-7
Bennett BD, Wilson CJ (1999) Spontaneous activity of neostriatal cholinergic interneurons in vitro. J Neurosci 19:5586-96
Berger B, Glowinski J (1978) Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures. Brain Res 147:29-45
Berkowicz DA, Trombley PQ (2000) Dopaminergic modulation at the olfactory nerve synapse. Brain Res 855:90-9
Bergquist F, Ruthven A, Ludwig M, Dutia MB (2006) Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats. J Physiol 577:857-68
Bianchi C, Rodi D, Marino S, Beani L, Siniscalchi A (2002) Dual effects of 5-HT4 receptor activation on GABA release from guinea pig hippocampal slices. Neuroreport 13:2177-80
Birthelmer A, Schweizer T, Jeltsch H, Jackisch R, Cassel JC (2002) 5,7-Dihydroxytryptamine lesions enhance and serotonergic grafts normalize the evoked overflow of acetylcholine in rat hippocampal slices. Eur J Neurosci Nov;16(10):1839-49
Birthelmer A, Ehret A, Amtage F, Forster S, Lehmann O, Jeltsch H, Cassel JC, Jackisch R (2003) Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents. Brain Res Bull 59:371-81
Bischoff S, Scatton B, Korf JB J (1979) Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Res 165:161-5
Bobker DH, Williams JT (1989) Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors. J Pharmacol Exp Ther 250:37-43
Bobker DH, Williams J (1990) Serotonin-mediated inhibitory postsynaptic potential in guinea pig prepositus hypoglossi and feedback inhibition by serotonin. J Physiol 422:447-42
Boeijinga PH, Boddeke HW (1996) Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res 721:59-65
Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71:1222-32
Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL (1990) Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Mol Pharmacol 38:92-101
Bramley JR, Sollars PJ, Pickard GE, Dudek FE (2005) 5-HT1B receptor-mediated presynaptic inhibition of GABA release in the suprachiasmatic nucleus. J Neurophysiol 93:3157-64
Breitenstein C, Korsukewitz C, Floel A, Kretzschmar T, Diederich K, Knecht S (2006) Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology 31:2552-64
Brog JS, Beinfeld MC (1992) Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor. J Pharmacol Exp Ther 260:343-8
Brown RE, Haas HL (1999) On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus. J Physiol 515:777-86
Buhot MC, Patra SK, Naili S (1995) Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur J Pharmacol 285:221-8
Bull DR, Bakhtiar R, Sheehan MJ (1991) Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric study in vitro. Neurosci Lett 134:41-4
Buzzi MG, Carter WB, Shimizu T, Heath H 3rd , Moskowitz MA (1991) Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30:1193-1200
Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-7
Cameron DL, Williams JT (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14:6763-7
Cangioli I, Baldi E, Mannaioni PF, Bucherelli C, Blandina P, Passani MB (2002) Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci 16:521-8
Cannon KE, Nalwalk JW, Stadel R, Ge P, Lawson D, Silos-Santiago I, Hough LB (2003) Activation of spinal histamine H3 receptors inhibits mechanical nociception. Eur J Pharmacol 470:139-47
Cannon KE, Hough LB (2005) Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. J Pain 6:193-200
Cannon KE, Chazot PL, Hann V, Shenton F, Hough LB, Rice FL (2007) Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 129:76-92
Cassel JC, Jeltsch H (1995) Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69:1-41
Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P (2003) Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci 23:6245-54
Cheng LL, Wang SJ, Gean PW (1998) Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 10:2163-72
Clapham J, Kilpatrick GJ (1992) Histamine H3 receptors modulate the release of [3 H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br J Pharmacol 107:919-23
Coge F, Guenin SP, Audinot V, Renouard-Try A, Beauverger P, Macia C, Ouvry C, Nagel N, Rique H, Boutin JA, Galizzi JP (2001) Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J 355:279-88
Consolo S, Wu CF, Fusi R (1987) D1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. J Pharmacol Exp Ther 242:300-5
Consolo S, Arnaboldi S, Giorgi S, Russi G, Ladinsky H (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 5:1230-2
Cooper AJ, Stanford IM (2001) Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro. Neuropharmacol 41:62-71
Cox B, Kerwin RW, Lee TF, Pycock CJ (1980) A dopamine-5-hydroxytryptamine link in the hypothalamic pathways which mediate heat loss in the rat. J Physiol 303:9-21
Dailly E, Chenu F, Renard CE, Bourin M (2004) Dopamine, depression and antidepressants. Fundam Clin Pharmacol 18:601-7
Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8:4025-34
Daubner SC, Lauriano C, Haycock JW, Fitzpatrick PF (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. Effects of dopamine and cAMP-dependent phosphorylation on enzyme activity. J Biol Chem 267:12639-46
Davila NG, Blakemore LJ, Trombley PQ (2003) Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture. J Neurophysiol 90:395-404
Delgado A, Sierra A, Querejeta E, Valdiosera RF, Aceves J (2000) Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience 95:1043-8
Di Carlo G, Ghi P, Orsetti M (2000) Effect of R-(−)-alpha-methylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 24:275-84
Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-56
Dimitriadou V, Rouleau A, Dam Trung Tuong M, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M (1994) Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3 -receptor modulation in rat lung and spleen. Clin Sci (Lond) 87:151-63
Dimitriadou V, Rouleau A, Trung Tuong MD, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M (1997) Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience 77:829-39
Dolezal V, Jackisch R, Hertting G, Allgaier C (1992) Activation of dopamine D1 receptors does not affect D2 receptor-mediated inhibition of acetylcholine release in rabbit striatum. Naunyn Schmiedeberg’s Arch Pharmacol 345:16-20
Doreulee N, Yanovsky Y, Flagmeyer I, Stevens DR, Haas HL, Brown RE (2001) Histamine H3 receptors depress synaptic transmission in the corticostriatal pathway. Neuropharmacology 40:106-13
Driessen B, Bultmann R, Goncalves J, Starke K (1996) Opposite modulation of noradrenaline and ATP release in guinea pig vas deferens through prejunctional β-adrenoceptors: evidence for the β2 subtype. Naunyn-Schmiedeberg’s Arch Pharmacol 353:564-71
Drukarch B, Stoof JC (1990) D2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47:361-76
Edwards E, Harkins K, Wright G, Henn FA (1991) 5-HT1B receptors in an animal model of depression. Neuropharmacology 30:101-5
Eglen RM, Wong EH, Dumuis A, Bockaert J (1995) Central 5-HT4 receptors. Trends Pharmacol Sci 16:391-8
Endou M, Poli E, Levi R (1994) Histamine H3 -receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels. J Pharmacol Exp Ther 269:221-9
Enero MA, Langer SZ (1975) Inhibition by dopamine of 3 H-noradrenaline release elicited by nerve stimulation in the isolated cat’s nictitating membrane. Naunyn Schmiedeberg’s Arch Pharmacol 289:179-203
Engleman EA, McBride WJ, Li TK, Lumeng L, Murphy JM (2003) Ethanol drinking experience attenuates (−)sulpiride-induced increases in extracellular dopamine levels in the nucleus accumbens of alcohol-preferring (P) rats. Alcohol Clin Exp Res 27:424-31
Ennis C, Kemp JD, Cox B (1981) Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J Neurochem 36:1515-20
Ensinger H, Majewski H, Hedler L, Starke K (1985) Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits. J Pharmacol Exp Ther 234:681-90
Enz A, Goldstein M, Meller E (1990) Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Mol Pharmacol 37:560-5
Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl 371:35-44
Fedele E, Fontana G, Munari C, Cossu M, Raiteri M (1999) Native human neocortex release- regulating dopamine D2 type autoreceptors are dopamine D2 subtype. Eur J Neurosci 11:2351-8
Ferre S, Artigas F (1995) Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neurosci Lett 187:61-4
Ferris CF, Melloni RH Jr, Koppel G, Perry KW, Fuller RW, Delville Y (1997) Vasopressin/ serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci 17:4331-40
Feuerstein TJ, Seeger W (1997) Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer’s disease. Pharmacol Ther 74:333-47
Feuerstein TJ, Hertting G, Lupp A, Neufang B (1986) False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3 H]-5-hydroxytryptamine. Br J Pharmacol 88:677-84
Feuerstein TJ, Gleichauf O, Landwehrmeyer GB (1996a) Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons. Naunyn-Schmiedeberg’s Arch Pharmacol 354:618-26
Feuerstein TJ, H üring H, van Velthoven V, L ücking CH, Landwehrmeyer GB (1996b) 5-HT1D -like receptors inhibit the release of endogenously formed [3 H]GABA in human, but not in rabbit, neocortex. Neurosci Lett 209:210-14
Fink K, Schlicker E, Neise A, G öthert M (1990) Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex. Naunyn-Schmiedeberg’s Arch Pharmacol 342:513-19
Floran B, Aceves J, Sierra A, Martinez-Fong D (1990) Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 116:136-40
Floran B, Floran L, Sierra A, Aceves J (1997) D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 237:1-4
Francis GS (1995) Receptor systems involved in norepinephrine release in heart failure: focus on dopaminergic systems. Clin Cardiol 18(3 Suppl I):I13-I16
Fuder H, Muscholl E (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126:265-412
Galzin AM, Dubocovich ML, Langer SZ (1982) Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus. J Pharmacol Exp Ther 221:461-71
Garcia M, Floran B, Arias-Montano JA, Young JM, Aceves J (1997) Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3 H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 80:241-9
Garcia-Ramirez M, Aceves J, Arias-Montano JA (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav Brain Res 154:409-15
Garduno-Torres B, Trevino M, Gutierrez R, Arias-Montano JA (2007) Pre-synaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus. Neuropharmacology 52:527-35
Geldwert D, Norris JM, Feldman IG, Schulman JJ, Joyce MP, Rayport S (2006) Dopamine presynaptically and heterogeneously modulates nucleus accumbens medium-spiny neuron GABA synapses in vitro. BMC Neurosci 7:53
Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-32
Giorgetti M, Bacciottini L, Bianchi L, Giovannini MG, Cecchi M, Blandina P (1997) GABAergic mechanism in histamine H3 receptor inhibition of K+ -evoked release of acetylcholine from rat cortex in vivo. Inflamm Res 46:S33-S34
Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, Millan MJ (1998) Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neurosci 84:413-29
G öthert M (2003) Modulation of noradrenaline release in human cardiovascular tissues. Pharmacol Toxicol 92:156-9
G öthert M, Schlicker E (1997) Regulation of 5-HT release in the CNS by presynaptic 5-HT autoreceptors and by 5-HT heteroreceptors. In: Baumgarten HG, Gö M (eds) Serotonergic Neurons and 5-HT Receptors in the CNS. Springer, Berlin Heidelberg New York, pp 307-50
G öthert M, Starke K (2005) Pharmakologie des Serotonins. Pharmakotherapie prim ärer Kopfschmerzen. In: Allgemeine und spezielle Pharmakologie und Toxikologie; Eds. K. Aktories, U. Förstermann, F. Hofmann, K. Starke, 9. edition, Urban & Fischer, M ünchen Jena, pp 213-19
G öthert M, Garbarg M, Hey JA, Schlicker E, Schwartz JC, Levi R (1995) New aspects of the role of histamine in cardiovascular function: identification, characterization, and potential pathophysiological importance of H3 receptors. Can J Physiol Pharmacol 73:558-64
G öthert M, Fink K, Frolich D, Likungu J, Molderings G, Schlicker E, Zentner J (1996) Presynaptic 5-HT auto- and heteroreceptors in the human central and peripheral nervous system. Behav Brain Res 73:89-92
Goldstein M, Harada K, Meller E, Schalling M, H ökfelt T (1990) Dopamine autoreceptors. Biochemical, pharmacological, and morphological studies. Ann N Y Acad Sci 604:169-75
Goldstein DS, Mezey E, Yamamoto T, Aneman A, Friberg P, Eisenhofer G (1995) Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. Hypertens Res Suppl 1:S93-9
Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, Sharabi Y (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333-9
Gomez-Ramirez J, Ortiz J, Blanco I (2002) Presynaptic H3 autoreceptors modulate histamine synthesis through cAMP pathway. Mol Pharmacol 61:239-45
Goncalves J, Bultmann R, Driessen B (1996) Opposite modulation of cotransmitter release in guinea pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors. Naunyn-Schmiedeberg’s Arch Pharmacol 353:184-92
Gonzalez-Islas C, Hablitz J (2001) Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J Neurophysiol 86:2911-18
Gorell JM, Czarnecki B (1986) Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 38:2239-46
Green S (1991) Benzodiazepines, putative anxiolytics and animal models of anxiety. Trends Neurosci 14:101-4
Guzman JN, Hernandez A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J (2003) Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum. J Neurosci 23:8931-40
Haeusler G, Lues I, Minck KO, Schelling P, Seyfried CA (1992) Pharmacological basis for antihypertensive therapy with a novel dopamine agonist. Eur Heart J 13 Suppl D:129-35
Hakansson K, Pozzi L, Usiello A, Haycock J, Borrelli E, Fisone G (2004) Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol. Eur J Neurosci 20:1108-12
Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21:68S-76S
Harada C, Fujii Y, Hirai T, Shinomiya K, Kamei C (2004) Inhibitory effect of iodophenpropit, a selective histamine H3 antagonist, on amygdaloid kindled seizures. Brain Res Bull 63:143-6
Hatta E, Yasuda K, Levi R (1997) Activation of histamine H3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther 283:494-500
Helmreich I, Reimann W, Hertting G, Starke K (1982) Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different? Neuroscience 7:1559-66
Hernandez A, Ibanez-Sandoval O, Sierra A, Valdiosera R, Tapia D, Anaya-Martinez V, Galarraga E, Bargas J, Aceves J (2006) Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine Receptors. J Neurophysiol 96:2877-88
Hertting G, Zumstein A, Jackisch R, Hoffmann I, Starke K (1980) Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. NaunynSchmiedeberg’s Arch Pharmacol 315:111-17
Huang YW, Hu WW, Chen Z, Zhang LS, Shen HQ, Timmerman H, Leurs R, Yanai K (2004) Effect of the histamine H3 -antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 151:287-93
Ibanez-Sandoval O, Hernandez A, Floran B, Galarraga E, Tapia D, Valdiosera R, Erlij D, Aceves J, Bargas J (2006) Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J Neurophysiol 95:1800-11
Ichinose M, Belvisi MG, Barnes PJ (1990) Histamine H3 -receptors inhibit neurogenic microvascular leakage in airways. J Appl Physiol 68:21-5
Ilani T, Fishburn CS, Levavi-Sivan B, Carmon S, Raveh L, Fuchs S (2002) Coupling of dopamine receptors to G proteins: studies with chimeric D2 /D3 dopamine receptors. Cell Mol Neurobiol 22:47-56
Imamura M, Poli E, Omoniyi AT, Levi R (1994) Unmasking of activated histamine H3 -receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271:1259-66
Imamura M, Seyedi N, Lander HM, Levi R (1995) Functional identification of histamine H3 receptors in the human heart. Circ Res 77:206-10
Imamura M, Smith NC, Garbarg M, Levi R (1996a) Histamine H3 -receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ Res 78:863-9
Imamura M, Lander HM, Levi R (1996b) Activation of histamine H3 -receptors inhibits carriermediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1 -receptors and α2 -adrenoceptors. Circ Res 78:475-81
Ishikawa S, Sperelakis N (1987) A novel class (H3 ) of histamine receptors on perivascular nerve terminals. Nature 327:158-60
Jackisch R, Moll S, Feuerstein TJ, Hertting G (1985) Dopaminergic modulation of hippocampal noradrenaline release. Evidence for α2 -antagonistic effects of some dopamine receptor agonists and antagonists. Naunyn-Schmiedeberg’s Arch Pharmacol 330:105-13
Jiang X, Chen A, Li H (2005) Histaminergic modulation of excitatory synaptic transmission in the rat basolateral amygdala. Neuroscience 131:691-703
Jin CY, Panula P (2005) The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation. Neuroscience 132:137-49
Johnson EA, Tsai CE, Lucci J, Harrison-Shahan Y, Azzaro AJ (1992a) Dopamine D2 synthesismodulating receptors are present in the striatum of the guinea pig. Neuropharmacology 31:95-101
Johnson SW, Mercuri NB, North RA (1992b) 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-6
Johnson EA, Tsai CE, Shahan YH, Azzaro AJ (1993) Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J Pharmacol Exp Ther 266:133-41
Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649-55
Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR, Caron MG, Wightman RM (2002) Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D3 receptors. Neuroscience 112:39-49
Joyce JN, Marshall JF (1987) Quantitative autoradiography of dopamine D2 sites in rat caudateputamen: localization to intrinsic neurons and not to neocortical afferents. Neuroscience 20:773-95
Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189-208
Katsurabayashi S, Kubota H, Tokutomi N, Akaike N (2003) A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology 44:1022-30
Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS (2005) G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptorfilamin-beta-arrestin complex. A case of autoreceptor regulation. J Biol Chem 280:12774-80
Koga E, Momiyama T (2000) Presynaptic dopamine D2 -like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol 523:163-73
Koyama S, Kubo C, Rhee JS, Akaike N (1999) Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. J Physiol 518:525-38
Koyama M, Heerdt PM, Levi R (2003) Increased severity of reperfusion arrhythmias in mouse hearts lacking histamine H3 -receptors. Biochem Biophys Res Commun 306:792-6
Koyama S, Brodie MS, Appel SB (2007) Ethanol inhibition of M-current and ethanol-induced direct excitation of ventral tegmental area dopamine neurons. J Neurophysiol 97:1977-85
Kuzhikandathil EV, Yu W, Oxford GS (1998) Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines. Mol Cell Neurosci 12:390-402
Kuzhikandathil EV, Oxford GS (1999) Activation of human D3 dopamine receptor inhibits P/Qtype calcium channels and secretory activity in AtT-20 cells. J Neurosci 19:1698-1707
Leclere PG Lefebvre RA (2002) Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach. Br J Pharmacol 135:135-42
LePard KJ, Ren J, Galligan J (2004) Presynaptic modulation of cholinergic and non-cholinergic fast synaptic transmission in the myenteric plexus of guinea pig ileum. Neurogastroenterol Motil 16:355-64
Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4:107-20
Levi R, Smith NC (2000) Histamine H3 -receptors: a new frontier in myocardial ischemia. J Pharmacol Exp Ther 292:825-30
Li M, Luo X, Chen L, Zhang J, Hu J, Lu B (2003) Co-localization of histamine and dopaminebeta-hydroxylase in sympathetic ganglion and release of histamine from cardiac sympathetic terminals of guinea pig. Auton Autacoid Pharmacol 23:327-33
Li M, Hu J, Chen Z, Meng J, Wang H, Ma X, Luo X (2006) Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system. Am J Physiol Heart Circ Physiol 291:45-51
Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hokfelt T, Fisone G (2001) Dopamine D2 receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur J Neurosci 13:773-80
Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G (2003) Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA 100:4305-9
Lintunen M, Sallmen T, Karlstedt K, Panula P (2005) Transient changes in the limbic histaminergic system after systemic kainic acid-induced seizures. Neurobiol Dis 20:155-69
L öffler M, Bubl B, Huethe F, Hubbe U, McIntosh JM, Jackisch R, Feuerstein TJ (2006) Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release. Brain Res Bull 68:361-73
Lokhandwala MF, Buckley JP (1978) The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors. J Pharmacol Exp Ther 204:362-71
Lucas G, Spampinato U (2000) Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J Neurochem 74:693-701
Malinina E, Druzin M, Johansson S (2005) Fast neurotransmission in the rat medial preoptic nucleus. Brain Res 1040:157-68
Mannelli M, Lazzeri C, Ianni L, La Villa G, Pupilli C, Bellini F, Serio M, Franchi F (1997) Dopamine and sympathoadrenal activity in man. Clin Exp Hypertens 19:163-79
Marcos B, Gil-Bea FJ, Hirst WD, Garcia-Alloza M, Ramirez MJ (2006) Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24:1299-1306
Marek GJ, Wright RA, Gewirtz JC, Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105:379-92
Matsubara T, Moskowitz MA, Huang Z (1992) UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 224:145-50
Matsumoto M, Yoshioka M, Togashi H, Ikeda T, Saito H (1996) Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study. NaunynSchmiedeberg’s Arch Pharmacol 353:621-9
Maurice N, Mercer J, Chan CS, Hernandez-Lopez S, Held J, Tkatch T, Surmeier DJ (2004) D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. J Neurosci 24:10289-301
Mayfield RD, Zahniser NR (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 59:113-21
Mazenot C, Ribuot C, Durand A, Joulin Y, Demenge P, Godin-Ribuot D (1999) In vivo demonstration of H3 -histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methylhistamine and its prodrug BP 2.94 in the dog. Br J Pharmacol 126:264-8
McLeod RL, Aslanian R, del Prado M, Duffy R, Egan RW, Kreutner W, McQuade R, Hey JA (1998) Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neuro-genic vascular inflammation and produces sedation in the guinea pig. J Pharmacol Exp Ther 287:43-50
Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764-7
Meyer DK, Krauss J (1983) Dopamine modulates cholecystokinin release in neostriatum. Nature 301:338-40
Mizuno T, Schmauss C, Rayport S (2007) Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of medium-spiny neurons in the nucleus accumbens. BMC Neurosci 8:8-23
Mizutani H, Hori T, Takahash T (2006) 5-HT1B receptor-mediated presynaptic inhibition at the calyx of Held of immature rats. Eur J Neurosci 24:1946-54
Molina-Hernandez A, Nunez A, Arias-Montano JA (2000) Histamine H3 -receptor activation inhibits dopamine synthesis in rat striatum. Neuroreport 11:163-6
Molina-Hernandez A, Nunez A, Sierra JJ, Arias-Montano JA (2001) Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 41:928-34
Momiyama T, Koga E (2001) Dopamine D2 -like receptors selectively block N-type Ca2+ channels to reduce GABA release onto rat striatal cholinergic interneurones. J Physiol 533:479-92
Monnet FP (2002) Functional cooperation between neurosteroids and D2 dopamine antagonists on KCl-evoked [3 H]noradrenaline release: modulation by calcium channel blockers. J Neuroendocrinol 14:955-62
Mooney RD, Shi MY, Rhoades RW (1994) Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster. J Neurophysiol 72:3-13
Moreno-Delgado D, Torrent A, Gomez-Ramirez J, de Esch I, Blanco I, Ortiz J (2006) Constitutive activity of H3 autoreceptors modulates histamine synthesis in rat brain through the cAMP/PKA pathway. Neuropharmacology 51:517-23
Morgadinho MT, Fontes Ribeiro CA, Macedo TR (1999) Presynaptic dopamine receptors involved in the inhibition of noradrenaline and dopamine release in the human gastric and uterine arteries. Fundam Clin Pharmacol 13:662-70
Morikawa H, Manzoni OJ, Crabbe JC, Williams JT (2000) Regulation of central synaptic transmission by 5-HT1B auto- and heteroreceptors. Mol Pharmacol 58:1271-8
Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408:860-4
Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Chaki S, Aihara H (1988a) 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Eur J Pharmacol 153:89-95
Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Aihara H (1988b) Serotonin-2 receptormediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat. Neuropharmacology 27:603-9
Muramatsu M, Lapiz MD, Tanaka E, Grenhoff J (1998) Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur J Neurosci 10:2371-9
Murphy MB (2000) Dopamine: a role in the pathogenesis and treatment of hypertension. J Hum Hypertens 14 Suppl 1:S47-S50
Nemmar A, Delaunois A, Beckers JF, Sulon J, Bloden S, Gustin P (1999) Modulatory effect of imetit, a histamine H3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur J Pharmacol 371:23-30
Nicola SM, Kombian SB, Malenka RC (1996) Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1 -like dopamine receptors. J Neurosci 16:1591-604
Nicola SM, Malenka RC (1997) Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. J Neurosci 17:5697-5710
Ng NK, Lee HS, Wong PT (1999) Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors. J Neurosci Res 55:600-7
Nguyen-Legros J, Versaux-Botteri C, Vernier P (1999) Dopamine receptor localization in the mammalian retina. Mol Neurobiol 19:181-204
Obadiah J, Avidor-Reiss T, Fishburn CS, Carmon S, Bayewitch M, Vogel Z, Fuchs S, LevaviSivan B (1999) Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs. Cell Mol Neurobiol 19:653-64
O’Hara CM, Uhland-Smith A, O’Malley KL, Todd RD (1996) Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J Pharmacol Exp Ther 277:186-92
Ohkubo T, Shibata M (1995) ATP-sensitive K+ channels mediate regulation of substance P release via the prejunctional histamine H3 receptor. Eur J Pharmacol 277:45-9
Pan WH, Yang SY, Lin SK (2004) Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53:44-52
Park KH, Long JP, Cannon JG (1991) Effects of serotonin1 -like receptor agonists on autonomic neurotransmission. Can J Physiol Pharmacol 69:1855-60
Passani MB, Cangioli I, Baldi E, Bucherelli C, Mannaioni PF, Blandina P (2001) Histamine H3 receptor-mediated impairment of contextual fear conditioning and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala. Eur J Neurosci 14:1522-32
Petty F, Kramer G, Wilson L (1992) Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacol Biochem Behav 43:361-7
Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM (2002) A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience 114:173-93
Pickard GE, Smith BN, Belenky M, Rea MA, Dudek FE, Sollars P (1999) 5-HT1B receptormediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. J Neurosci 19:4034-45
Piguet P, Galvan M (1994) Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. J Physiol 481:629-39
Pineyro G, de Montigny C, Blier P (1995a) 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacology 13:249-60
Pineyro G, Castanon N, Hen R, Blier P (1995b) Regulation of [3 H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice. Neuroreport 7:353-9
Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G (2000) Activation of D2 -like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci 20: RC69 (1-6)
Popova NK (2006) From genes to aggressive behavior: the role of serotonergic system. Bioessays 28:495-503
Pothos EN, Przedborski S, Davila V, Schmitz Y, Sulzer D (1998) D2 -Like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci 18:5575-85
Prasad BM, Amara SG (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci 21:7561-7
Prast H, Tran MH, Fischer H, Kraus M, Lamberti C, Grass K, Philippu A (1999a) Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 360:558-64
Prast H, Tran MH, Lamberti C, Fischer H, Kraus M, Grass K, Philippu A (1999b) Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 360:552-7
Price CJ, Pittman QJ (2001) Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus. J Neurophysiol 86:1149-55
Racagni G, Canonico PL, Ravizza L, Pani L, Amore M (2004) Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology 50:134-43
Radnikow G, Misgeld U (1998) Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J Neurosci 18:2009-16
Raiteri M (2006) Functional pharmacology in human brain. Pharmacol Rev 58:162-93
Raiteri M, Maura G, Bonanno G, Pittaluga A (1986) Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther 237:644-8
Rothblat DS, Schneider JS (1997) Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci Lett 228:119-22
Roy-Byrne PP (2005) The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety. J Clin Psychiatry 66 Suppl 2:14-20
Ruh é HG, Mason NS, Schene AH (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12:331-59
Rump LC, Schwertfeger E, Schaible U, Schuster MJ, Frankenschmidt A, Schollmeyer P (1993) Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices. Eur J Clin Pharmacol 44 Suppl 1:S47-S49
Rump LC, Riera-Knorrenschild G, Schwertfeger E, Bohmann C, Spillner G, Schollmeyer P (1995) Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium. J Cardiovasc Pharmacol 26:462-70
Rutz S, Riegert C, Rothmaier AK, Buhot MC, Cassel JC, Jackisch R (2006) Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B -receptor knockout mice. Brain Res Bull 70:81-93
Rutz S, Riegert C, Rothmaier AK, Jackisch R (2007) Presynaptic modulation of 5-HT release in the rat septal region. Neurosci 146:643-58
Sarhan H, Cloez-Tayarani I, Massot O, Fillion MP, Fillion G (1999) 5-HT1B receptors modulate release of [3 H] dopamine from rat striatal synaptosomes. Naunyn Schmiedeberg’s Arch Pharmacol 359:40-7
Sarhan H, Fillion G (1999) Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedeberg’s Arch Pharmacol 360:382-90
Sarhan H, Grimaldi B, Hen R, Fillion G (2000) 5-HT1B receptors modulate release of [3 H] dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Naunyn Schmiedebergs Arch Pharmacol 361:12-18
Sari Y (2004) Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28:565-82
Sehmisch S, Blauth E, Thorn D, Cassel JC, Kelche C, Feuerstein TJ, Jackisch R (2001) Electrically evoked release of glutamate in rat hippocampal slices: effects of various drugs and fimbriafornix lesions. Naunyn-Schmiedeberg’s Arch Pharmacol 363:481-90
Schlicker E, G öthert M (1998) Interactions between the presynaptic α2 -autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47:129-32
Schlicker E, Betz R, G öthert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg’s Arch Pharmacol 337:588-90
Schlicker E, Fink K, Hinterthaner M, G öthert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedeberg’s Arch Pharmacol 340:633-8
Schlicker E, Fink K, Detzner M, G öthert M (1993) Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect 93:1-10
Schlicker E, Kathmann M, Detzner M, Exner HJ, G öthert M (1994) H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase. Naunyn Schmiedeberg’s Arch Pharmacol 350:34-41
Schlicker E, Werthwein S, Zentner J (1999) Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain. Fundam Clin Pharmacol 13:120-2
Schmitz D, Gloveli T, Empson RM, Draguhn A, Heinemann U (1998) Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism. J Physiol 508:119-29
Schmitz Y, Schmauss C, Sulzer D (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 22:8002-9
Schoffelmeer AN, Hogenboom F, Mulder AH, Ronken E, Stoof JC, Drukarch B (1994) Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors. Synapse. 17:190-5
Schwartz JC, Arrang JM, Garbarg M, Korner M (1986) Properties and roles of the three subclasses of histamine receptors in brain. J Exp Biol 124:203-24
Seyfried CA, Bartoszyk GD (1994) Sensitivity of dopamine D2 receptors following long-term treatment with roxindole. Eur J Pharmacol 257:67-72
Silver RB, Poonwasi KS, Seyedi N, Wilson SJ, Lovenberg TW, Levi R (2002) Decreased intracellular calcium mediates the histamine H3 -receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc Natl Acad Sci USA 99:501-6
Singer JH, Bellingham MC, Berger AJ (1996) Presynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin. J Neurophysiol 76:799-807
Siniscalchi A, Badini I, Beani L, Bianchi C (1999) A5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices. Neuroreport 10:547-51
Smits RPJM, Mulder AH (1991) Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem Int 18:215-20
Sprouse JS, Aghajanian GK (1986) (−)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295-8
Stark H, Kathmann M, Schlicker E, Schunack W, Schlegel B, Sippl W (2004) Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists. Mini Rev Med Chem 4:965-77
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
Starke K (1981) Presynaptic receptors. Annu Rev Pharmacol Toxicol 21:7-30
Starke K, Weitzell R (1978) Is histamine involved in the sympathomimetic effect of nicotine? Naunyn-Schmiedeberg’s Arch Pharmacol 304:237-48
Starke K, G öthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864-89
Stoof JC, De Boer T, Sminia P, Mulder AH (1982) Stimulation of D2 -dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol 84:211-14
Subramony JA (2006) Apomorphine in dopaminergic therapy. Mol Pharmaceut 3:380-5
Takeshita Y, Watanabe T, Sakata T, Munakata M, Ishibashi H, Akaike N (1998) Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience 87:797-805
Takeuchi S, Sugiyama Y, Mano T, Iwase S, Matsukawa T (1993) Effect of L-dopa on human muscle sympathetic nerve activity. Environ Med 37:99-102
Tanaka E, North RA (1993) Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69:1749-57
Tanaka S, Ichikawa A (2006) Recent advances in molecular pharmacology of the histamine systems: immune regulatory roles of histamine produced by leukocytes. J Pharmacol Sci 101:19-23
Tang L, Todd RD, O’Malley KL (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther 270:475-9
Thielen RJ, Engleman EA, Rodd ZA, Murphy JM, Lumeng L, Li TK, McBride WJ (2004) Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats. J Pharmacol Exp Ther 309:216-25
Thompson TL, Certain ME (2005) Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o. Eur J Pharmacol 511:121-6
Threlfell S, Cragg SJ, Kallo I, Turi GF, Coen CW, Greenfield SA (2004) Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J Neurosci 24:8704-10
Travagli RA, Williams J T (1996) Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea pig. J Physiol 491:177-85
Trendelenburg AU, Meyer A, Klebroff W, Guimaraes S, Starke K (2003) Crosstalk between presynaptic angiotensin receptors, bradykinin receptors and α2 -autoreceptors in sympathetic neurons: a study in α2 -adrenoceptor-deficient mice. Br J Pharmacol 138:1389-1402
Uchida H, Takeuchi H, Suzuki T, Nomura K, Watanabe K, Kashima H (2005) Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder. J Clin Psychopharmacol 25:545-51
Umemiya M, Berger AJ (1995) Presynaptic inhibition by serotonin of glycinergic inhibitory synaptic currents in the rat brain stem. J Neurophysiol 73:1192-1201
Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M, Piazza PV, Borrelli E (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408:199-203
Vanderschuren LJ, Wardeh G, De Vries TJ, Mulder AH, Schoffelmeer AN (1999) Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. J Neurosci 19:4123-31
Varty LM, Gustafson E, Laverty M, Hey JA (2004) Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 484:83-9
Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443-52
Weber B, Schlicker E, Sokoloff P, Stark H (2001) Identification of the dopamine autoreceptor in the guinea pig retina as D2 receptor using novel subtype-selective antagonists. Br J Pharmacol 133:1243-8
Westerink BH, Cremers TI, De Vries JB, Liefers H, Tran N, De Boer P (2002) Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse 43:238-43
Wieczorek WJ, Kruk ZL (1994) A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice. Brain Res 657:42-50
Willems JL, Buylaert WA, Lefebvre RA, Bogaert MG (1985) Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 37:165-216
Wu SY, Wang MY, Dun NJ (1991) Serotonin via presynaptic 5-HT1 receptors attenuates synaptic transmission to immature rat motoneurons in vitro. Brain Res 554:111-21
Yamamoto Y, Mochizuki T, Okakura-Mochizuki K, Uno A, Yamatodani A (1997) Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus. Methods Find Exp Clin Pharmacol 19:289-98
Yan Z, Song WJ, Surmeier J (1997) D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-Cinsensitive pathway. J Neurophysiol 77:1003-15
Yokoo H, Goldstein M, Meller E (1988) Receptor reserve at striatal dopamine receptors modulating the release of [3 H] dopamine. Eur J Pharmacol 155:323-7
Yokoyama H, Onodera K, Maeyama K, Sakurai E, Iinuma K, Leurs R, Timmerman H, Watanabe T (1994) Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur J Pharmacol 260:23-8
Yoshimoto R, Miyamoto Y, Shimamura K, Ishihara A, Takahashi K, Kotani H, Chen AS, Chen HY, Macneil DJ, Kanatani A, Tokita S (2006) Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus. Proc Natl Acad Sci USA, in press
Young CS, Mason R, Hill SJ (1988) Studies on the mechanism of histamine-induced release of noradrenaline and 5-hydroxytryptamine from slices of rat cerebral cortex. Biochem Pharmacol 37:2799-2805
Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-30
Yu C, Shen Y, Xu L, Zhu Y, Zhuge Z, Huang Y, Henk T, Rob L, Wei E, Chen Z (2006) Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats. Physiol Behav 87:687-93
Zhang LS, Chen Z, Huang YW, Hu WW, Wei EQ, Yanai K (2003) Effects of endogenous histamine on seizure development of pentylenetetrazole-induced kindling in rats. Pharmacology 69:27-32
Zaragoza F, Stephensen H, Knudsen SM, Pridal L, Wulff BS, Rimvall K (2004) 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem 47:2833-8
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Feuerstein, T.J. (2008). Presynaptic Receptors for Dopamine, Histamine, and Serotonin. In: Südhof, T.C., Starke, K. (eds) Pharmacology of Neurotransmitter Release. Handbook of Experimental Pharmacology, vol 184. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74805-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-74805-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74804-5
Online ISBN: 978-3-540-74805-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)